WILMINGTON, Del., April 25, 2016 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC ), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, has signed a definitive agreement to sell the Disinfectants, Oxone ® and Chlorine Dioxide business lines (Clean and Disinfect Business) of its Chemical Solutions segment to specialty chemicals group LANXESS for $230 million in cash. The company anticipates closing the transaction within the second half of 2016, subject to customary closing conditions and regulatory approvals. "Today marks another important step in our five-point transformation plan," said Mark Vergnano, Chemours president and CEO. "This agreement, along with the recent sale of our Beaumont aniline facility, illustrates the significant progress we are making to streamline our portfolio and improve our liquidity position."